FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:739-740 March 16, 1995 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Human immunodeficiency virus (HIV) infection has become a chronic disease that lasts at least 10 to 15 years. One of the major clinical advances has been the implementation in the mid-1980s of antimicrobial prophylaxis for patients with severe immune impairment. Together with the use of antiretroviral drugs, this prophylaxis has led to decreased morbidity and improved survival among patients with AIDS. So far, recommendations have been issued for primary prophylaxis against Pneumocystis carinii pneumonia, infection with Mycobacterium avium complex, and tuberculosis. There are reports and ongoing studies of strategies for preventing infections caused by Toxoplasma gondii, cytomegalovirus, and some fungi. . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Obaji, J., Lee-Pack, L. R., Gutierrez, C., Chan, C. K.N. (2003). The Pulmonary Effects of Long-term Exposure to Aerosol Pentamidine: A 5-Year Surveillance Study in HIV-Infected Patients. Chest 123: 1983-1987 [Abstract] [Full Text]  
• (1995). Which Prophylactic Agent for PCP?. AIDS Clin Care 1995: 3-3 [Full Text]  
• (1995). Prophylaxis against P. carinii Pneumonia: Three Drugs Compared. Journal Watch Dermatology 1995: 16-16 [Full Text]  
• (1995). PROPHYLAXIS AGAINST P. CARINII PNEUMONIA: THREE DRUGS COMPARED. JWatch General 1995: 1-1 [Full Text]